PRKAA2 and hereditary elliptocytosis: The HE treatment had no significant effect on the mRNA level of AMP-activated protein kinase α1 (AMPKα1) or AMP-activated protein kinase α2 (AMPKα2) compared with the control (P > 0.1, Fig. 1).